All practice questions

1687 questions

Question 821Question →

A 28-year-old man is brought to the emergency department after sustaining a stab wound to the right lower chest during an altercation. On arrival, his blood pressure is 115/75 mmHg, heart rate is 105/min, and respiratory rate is 22/min. Oxygen saturation is 94% on room air. Primary survey reveals a 2-cm laceration in the right fifth intercostal space at the midaxillary line. The trachea is midline. Breath sounds are decreased over the right hemithorax, and dullness to percussion is noted at the right lung base. An extended bedside focused assessment with sonography for trauma (eFAST) confirms a moderate right-sided hemothorax. Two large-bore intravenous lines are established, and fluid resuscitation is initiated.

Arrange the following steps in the most appropriate sequential order for the standard evaluation and management of this patient's injury.

Drag items to arrange them in the correct order

Show answer & explanation

Answer

The correct algorithmic sequence is: 1) Perform a tube thoracostomy, 2) Obtain a portable chest radiograph, 3) Quantify ongoing drainage, and 4) Proceed to thoracotomy if criteria are met.
The standard management of a traumatic hemothorax requires a structured, stepwise algorithmic approach to ensure patient safety and avoid unnecessary invasive surgery. The primary intervention is the insertion of a large-bore tube thoracostomy. This procedure serves multiple purposes: it evacuates accumulated blood, allows the lung to re-expand (which can help tamponade bleeding vessels), and provides a method to measure blood loss. Immediately following insertion, a portable chest radiograph must be obtained to confirm the tube is in the correct position and that the hemothorax has been adequately drained. Once placement is confirmed, the clinician must continuously quantify the volume of ongoing blood drainage. This strict monitoring is critical because it dictates whether further intervention is needed. Most hemothoraces are self-limiting and stop bleeding once the lung is expanded. However, if the continuous drainage exceeds 200 mL/hr for 2 to 4 consecutive hours, or if the initial rush of blood exceeds 1,500 mL, this indicates massive ongoing hemorrhage from a major vascular or parenchymal injury. In such cases, the patient must immediately proceed to the final algorithmic step: an exploratory thoracotomy or video-assisted thoracoscopic surgery (VATS) to achieve definitive surgical hemostasis.

Step-by-Step Solution

1
Evaluate the patient's clinical presentation and imaging findings.
The patient is hemodynamically stable but has a confirmed moderate hemothorax resulting from penetrating thoracic trauma.
Identifying the specific intrathoracic injury directs the appropriate surgical or procedural intervention.
2
Determine the first therapeutic step.
A tube thoracostomy must be performed.
Evacuating the pleural space prevents tension physiology, re-expands the lung to help tamponade bleeding, and allows for quantification of blood loss.
3
Identify the immediate post-procedural requirement.
A portable chest radiograph is obtained.
Imaging is mandatory after placing a chest tube to verify that it is correctly positioned within the pleural cavity and that the lung has successfully re-expanded.
4
Establish the ongoing monitoring plan.
The chest tube drainage must be carefully quantified.
Monitoring the hourly output is essential to detect ongoing, non-compressible intrathoracic bleeding.
5
Identify the threshold for definitive open surgery.
An exploratory thoracotomy is performed if specific bleeding criteria are met.
Surgery is indicated if initial drainage is >1,500 mL or if ongoing drainage exceeds 200 mL/hr for 2 to 4 consecutive hours.

Key Concept

The standard management algorithm for a traumatic hemothorax begins with a tube thoracostomy, followed immediately by radiographic confirmation of tube placement, strict monitoring of drainage volume, and finally an exploratory thoracotomy only if criteria for massive or ongoing hemorrhage are met.
Question 822Question →

Following a near-miss incident involving an improperly loaded decentralized automated medication dispensing system on an inpatient ward, a hospital's patient safety committee decides to proactively evaluate the entire medication dispensing workflow. The goal is to systematically identify and mitigate system vulnerabilities before a harmful medication error occurs by conducting a Failure Mode and Effects Analysis (FMEA). Arrange the procedural steps of the FMEA process in the correct chronological sequence from start to finish.

Drag items to arrange them in the correct order

Show answer & explanation

Answer

The correct chronological sequence for a Failure Mode and Effects Analysis (FMEA) is: 1) Assemble the team and map the process, 2) Identify potential failure modes, 3) Calculate risk priority numbers, 4) Implement targeted interventions, and 5) Reassess the system post-implementation.
Failure Mode and Effects Analysis (FMEA) follows a structured, proactive sequence. It begins by assembling a multidisciplinary team to comprehensively map a high-risk process. The team then brainstorms potential failure modes at each step of that mapped process. Next, a risk priority number (RPN) is calculated by multiplying the severity, occurrence, and detectability of each specific failure mode. The highest RPNs guide the development and implementation of targeted, system-level interventions. Finally, the process is reassessed to ensure the interventions successfully reduced the targeted vulnerabilities.

Step-by-Step Solution

1
Identify the initial setup requirement for FMEA.
Assemble a multidisciplinary team and map the process.
An accurate proactive analysis requires diverse perspectives and a clear understanding of the current operational workflow.
2
Determine the next action after mapping the process steps.
Identify all potential failure modes.
You must define exactly what could go wrong within the mapped workflow before you can measure its impact or design a fix.
3
Establish a method to prioritize the identified failures.
Calculate the risk priority number (RPN).
Not all failure modes pose the same threat; calculating the RPN (Severity × Occurrence × Detectability) identifies which vulnerabilities require immediate attention.
4
Address the highest priority risks identified by the RPN.
Develop and implement risk reduction strategies.
The primary goal of FMEA is proactive risk mitigation through durable, system-level changes rather than individual vigilance.
5
Ensure the implemented interventions were successful.
Reassess the system post-implementation.
Continuous quality improvement requires verifying that the systematic changes actually reduced the risk of failure.

Key Concept

Failure Mode and Effects Analysis (FMEA) is a prospective, systematic quality improvement framework used to identify, prioritize, and mitigate process vulnerabilities before an adverse event reaches a patient.
Question 823Question →

A 72-year-old woman is brought to the emergency department after a syncopal episode. She is currently conscious but complains of severe dizziness and chest pressure. Her blood pressure is 80/50 mm Hg, and her heart rate is 35/min. Arrange the following management steps in the most appropriate chronological sequence according to standard Advanced Cardiovascular Life Support (ACLS) guidelines for symptomatic bradycardia.

Drag items to arrange them in the correct order

Show answer & explanation

Answer

The correct sequence for managing symptomatic bradycardia is: 1) Establish intravenous access and obtain a 12-lead ECG, 2) Administer a rapid intravenous dose of atropine, 3) Initiate transcutaneous pacing, and 4) Insert a temporary transvenous pacemaker.
According to the ACLS algorithm for symptomatic bradycardia, the initial step is to maintain the airway, provide oxygen if hypoxemic, establish IV access, and obtain a 12-lead ECG. Once the patient is deemed unstable (e.g., hypotension, ischemic chest discomfort), the first-line intervention is IV atropine. If atropine is ineffective, the next step is transcutaneous pacing (or IV dopamine/epinephrine infusion). If these measures fail, expert consultation for temporary transvenous pacing is indicated.

Step-by-Step Solution

1
Identify the clinical condition
The patient has symptomatic bradycardia with signs of hemodynamic instability (hypotension, chest pressure).
Recognizing instability dictates immediate movement down the ACLS symptomatic bradycardia algorithm.
2
Perform initial stabilization
Establish intravenous access and obtain a 12-lead electrocardiogram.
Before administering medications, it is crucial to ensure IV access and properly identify the underlying rhythm.
3
Administer first-line pharmacotherapy
Administer a rapid intravenous dose of atropine.
Atropine is the primary medication used to treat symptomatic bradycardia by exerting a vagolytic action on the atrioventricular node.
4
Provide second-line interventions if needed
Initiate transcutaneous pacing.
If atropine is ineffective or contraindicated, transcutaneous pacing (or chronotropic infusions) should be initiated.
5
Provide definitive or advanced therapy
Insert a temporary transvenous pacemaker.
If non-invasive measures fail or as a bridge to permanent pacing, expert consultation and transvenous pacing are required.

Key Concept

Advanced Cardiovascular Life Support (ACLS) Symptomatic Bradycardia Algorithm
Estimated Time:1m 0s
Question 824Question →

A large tertiary care center is preparing to integrate a novel, automated continuous insulin infusion algorithm into the electronic health record (EHR) for the medical intensive care unit. Because intravenous insulin administration is highly prone to errors, the patient safety committee decides to proactively evaluate this system prior to its deployment. They initiate a Failure Mode and Effects Analysis (FMEA). Arrange the following procedural steps of the FMEA in the correct chronological sequence.

Drag items to arrange them in the correct order

Show answer & explanation

Answer

The correct chronological sequence for a Failure Mode and Effects Analysis (FMEA) is: 1) Assemble a multidisciplinary task force, 2) Construct a detailed graphical representation of the workflow, 3) Systematically identify potential defects, 4) Quantify risk via priority scores, 5) Formulate systems changes, and 6) Estimate residual risk.
Failure Mode and Effects Analysis (FMEA) is a highly structured, prospective tool used to evaluate complex processes before they go live. The sequence begins with defining the team. Once formed, the team maps the exact process (process mapping). Only after the steps are explicitly defined can the team brainstorm potential failure modes at each step. These modes are then objectively quantified using a Risk Priority Number (RPN)—calculated by multiplying severity, probability of occurrence, and likelihood of detection. High-RPN items are addressed with targeted interventions (e.g., forcing functions). Finally, the team must recalculate the expected RPN to ensure the residual risk is acceptable prior to full implementation.

Step-by-Step Solution

1
Assemble a multidisciplinary task force consisting of endocrinologists, intensivists, nursing staff, and clinical informaticists.
A diverse team with subject matter expertise is formed.
Prospective risk analysis requires input from frontline workers and specialists who understand the real-world application of the process.
2
Construct a detailed graphical representation of the proposed insulin ordering and administration workflow.
A process map is created.
The team must have a shared, visual understanding of the precise sequence of events before they can identify where things might go wrong.
3
Systematically identify potential defects or breakdown points at each step of the newly modeled workflow.
A list of potential failure modes is generated.
By anchoring brainstorming to the process map, the team ensures no step is overlooked when identifying vulnerabilities.
4
Quantify the severity, occurrence probability, and detectability of each identified defect to establish priority scores.
Risk Priority Numbers (RPN) are calculated for every failure mode.
Not all risks are equal. The RPN allows the team to objectively prioritize which vulnerabilities require immediate intervention.
5
Formulate and integrate high-reliability systems changes targeting the vulnerabilities with the highest priority scores.
Action plans and forcing functions are designed.
Interventions must be targeted at the most critical points of failure to effectively enhance system safety.
6
Estimate the residual risk by recalculating priority scores assuming the successful implementation of the proposed systems changes.
New, lower projected RPNs are documented.
Re-evaluation ensures that the proposed interventions theoretically lower the risk to an acceptable threshold before actual deployment.

Key Concept

Failure Mode and Effects Analysis (FMEA) is a prospective, proactive quality improvement process used to identify and mitigate potential systems failures before a new workflow or technology is implemented.
Estimated Time:1m 45s
Question 825Question →

A 5252-year-old man with a history of recurrent pulmonary infections and bronchiectasis is brought to the emergency department after coughing up approximately 700700 mL of bright red blood over the past two hours. On arrival, he is in severe respiratory distress, lethargic, and coughing continuously. Vital signs show a temperature of 37.2∘C37.2^\circ\text{C} (99.0∘F99.0^\circ\text{F}), blood pressure of 88/54 mm Hg88/54\text{ mm Hg}, pulse of 128/min128\text{/min}, and respiratory rate of 28/min28\text{/min}. Oxygen saturation is 85%85\% on high-flow oxygen. Auscultation reveals coarse crackles and diminished breath sounds over the right hemithorax. Large-bore intravenous access is established. Arrange the following interventions in the most appropriate sequential order for the acute management of this patient's condition.

Drag items to arrange them in the correct order

Show answer & explanation

Answer

The correct sequence follows the ABCs of resuscitation: secure the airway, protect the breathing (positioning), stabilize circulation, perform diagnostic bronchoscopy, and conclude with definitive embolization.
The algorithmic approach to massive hemoptysis follows standard resuscitation principles. The paramount initial step is securing the airway via endotracheal intubation to prevent asphyxiation, especially given the patient's lethargy and hypoxia. Following airway protection, the patient should be placed with the bleeding lung in the dependent position (right lateral decubitus in this case, given right-sided crackles) to protect the unaffected lung. Once the airway and breathing are managed, hemodynamic resuscitation (Circulation) with intravenous fluids and blood products is optimized. After stabilization, bronchoscopy is performed to clear clots, localize the specific bleeding site, and attempt local hemostatic maneuvers. Finally, as definitive therapy, bronchial artery embolization is performed.

Step-by-Step Solution

1
Secure the airway via endotracheal intubation
Prevents asphyxiation and allows for effective mechanical ventilation and suctioning.
The patient is lethargic, hypoxic, and actively bleeding into his airways, making immediate airway protection the most critical life-saving priority.
2
Place the patient in the right lateral decubitus position
Uses gravity to keep blood pooled in the right lung.
The right lung is the suspected source of bleeding based on localized crackles. Placing it dependent protects the healthy left lung from aspiration of blood.
3
Administer intravenous crystalloid and blood product resuscitation
Restores intravascular volume and improves hemodynamics.
The patient is hypotensive and tachycardic, requiring immediate cardiovascular support (the Circulation step of the ABC algorithm).
4
Perform urgent bronchoscopy
Visualizes the airways to precisely locate the bleeding source.
Once stabilized, bronchoscopy allows for diagnosis and initial local hemostatic interventions (e.g., balloon tamponade or cold saline lavage).
5
Proceed with bronchial artery embolization
Stops the arterial bleeding source permanently.
This is the gold-standard definitive treatment for massive hemoptysis when initial procedural stabilization cannot achieve permanent hemostasis.

Key Concept

The management of massive hemoptysis strictly follows the ABCs of resuscitation: Airway protection (intubation), Breathing maintenance (positioning the bleeding lung dependent), and Circulation support (fluids/blood), followed by diagnostic bronchoscopy and definitive bronchial artery embolization.
Question 826Question →

A 72-year-old female presents to the gynecology clinic reporting a six-month history of severe vulvar pruritus and a painful, non-healing sore. Her past medical history is significant for hypertension and lichen sclerosus. Physical examination reveals a 3.5-cm ulcerated, indurated plaque located on the right labium majus. Palpation of the right inguinal region identifies a firm, mobile, 1.5-cm lymph node. The left groin is unremarkable. Arrange the following steps in the most appropriate chronological sequence for the diagnosis and management of this patient's condition.

Drag items to arrange them in the correct order

Show answer & explanation

Answer

The correct sequence is: punch biopsy of the lesion, cross-sectional pelvic imaging, radical partial excision with lymph node evaluation, adjuvant radiation therapy (if indicated by surgical pathology), and finally, long-term clinical surveillance.
The standard of care for a newly discovered, highly suspicious vulvar lesion with associated lymphadenopathy strictly follows a diagnostic and therapeutic pathway. It begins with a minimally invasive biopsy for definitive tissue diagnosis. Once confirmed, advanced imaging helps stage the disease and plan the surgical approach. Primary surgical resection with lymph node evaluation provides both definitive local control and complete pathological staging. Based on the pathological findings, adjuvant radiation may be administered to reduce recurrence risk. Finally, because of the risk of recurrence, lifelong surveillance is mandated.

Step-by-Step Solution

1
Establish a tissue diagnosis.
Confirmation of invasive squamous cell carcinoma of the vulva.
Radical surgical procedures must not be undertaken without definitive histological proof of malignancy.
2
Perform locoregional staging with imaging.
Assessment of local tumor extension and evaluation of pelvic/inguinal lymphadenopathy.
Imaging aids in surgical planning and determines the feasibility of primary resection versus the need for neoadjuvant therapies.
3
Execute primary surgical management.
Removal of the primary tumor with negative margins and pathological staging of the regional lymph nodes.
Surgery is the cornerstone of curative-intent treatment for early-stage vulvar cancer.
4
Determine the need for adjuvant therapy.
Eradication of microscopic residual disease in high-risk patients.
Adjuvant radiation decreases the risk of locoregional recurrence in patients with positive nodes or close margins.
5
Conduct long-term follow-up.
Early detection of potential disease recurrence.
Vulvar cancer has a propensity for local recurrence, necessitating lifelong periodic physical examinations.

Key Concept

Sequential management of vulvar squamous cell carcinoma
Question 827Question →

A 32-year-old woman presents to the clinic with a 6-month history of progressive exertional dyspnea, fatigue, and occasional exertional syncope. Physical examination reveals a right ventricular heave, a loud pulmonic component of the second heart sound (P2), and clear lung fields. A transthoracic echocardiogram demonstrates right atrial and ventricular enlargement with an estimated right ventricular systolic pressure of 65 mm Hg65 \text{ mm Hg}. Left ventricular size and function are normal, with no left-sided valvular abnormalities. Arrange the following diagnostic and therapeutic steps in the most appropriate sequential order for the standard evaluation and definitive management of this patient's condition.

Drag items to arrange them in the correct order

Show answer & explanation

Answer

The correct sequence for evaluating and managing unexplained pulmonary hypertension is: 1) V/Q scan, 2) Right heart catheterization, 3) Vasoreactivity testing, 4) Calcium channel blocker trial (if reactive), and 5) Escalation to advanced PAH therapies if efficacy wanes.
The evaluation of pulmonary hypertension follows a rigorous, stepwise algorithm. Following echocardiographic suspicion, the first mandatory step is a V/Q scan to rule out chronic thromboembolic pulmonary hypertension (CTEPH), which is potentially curable surgically. Once CTEPH and left-heart/lung diseases are excluded, a right heart catheterization (RHC) is performed to definitively diagnose pre-capillary pulmonary arterial hypertension (PAH). During the RHC, acute vasoreactivity testing is essential. Patients who demonstrate a reactive hemodynamic profile are initiated on high-dose calcium channel blockers. If a patient initially responds to CCBs but later deteriorates, or if they are non-reactive from the start, therapy is escalated to targeted PAH agents such as endothelin receptor antagonists or phosphodiesterase-5 inhibitors.

Step-by-Step Solution

1
Rule out Group 4 Pulmonary Hypertension (CTEPH)
Perform a V/Q scan to look for mismatched perfusion defects.
CTEPH is uniquely treatable with pulmonary thromboendarterectomy. It must be evaluated prior to invasive hemodynamics or medical therapy.
2
Confirm diagnosis hemodynamically
Perform right heart catheterization (RHC).
Echocardiography only estimates pressures. RHC is required to confirm pre-capillary pulmonary hypertension (mPAP>20 mm Hg\text{mPAP} > 20 \text{ mm Hg}, PCWP≤15 mm Hg\text{PCWP} \leq 15 \text{ mm Hg}, PVR≥2 WU\text{PVR} \geq 2 \text{ WU}).
3
Determine phenotype for medical therapy
Administer a short-acting vasodilator (e.g., inhaled nitric oxide) during the RHC.
Vasoreactivity testing identifies the minority of patients with idiopathic PAH who will respond favorably to calcium channel blockers.
4
Initiate first-line therapy for reactive patients
Start high-dose calcium channel blockers (CCBs).
Reactive patients have an excellent prognosis on CCBs and should be treated with them initially.
5
Manage treatment failure or disease progression
Escalate to targeted PAH therapies (e.g., ERAs, PDE-5 inhibitors, or prostacyclin analogs).
Patients who lose reactivity or clinically deteriorate on CCBs require advanced, pathway-specific pulmonary vasodilators.

Key Concept

The diagnostic algorithm for suspected pulmonary arterial hypertension requires non-invasive screening for CTEPH via a V/Q scan, followed by definitive hemodynamic confirmation via right heart catheterization with concurrent vasoreactivity testing to guide targeted pharmacotherapy.
Estimated Time:1m 30s
Question 828Question →

A 54-year-old man with a known history of alcohol-associated cirrhosis presents to the emergency department after vomiting a large amount of bright red blood. On presentation, his blood pressure is 85/55 mm Hg, and his pulse is 120/min. He is lethargic but is maintaining his airway and oxygenating well on room air. Arrange the following management steps in the most appropriate chronological sequence.

Drag items to arrange them in the correct order

Show answer & explanation

Answer

The correct chronological sequence for managing acute variceal bleeding is to first ensure hemodynamic stability with intravenous access and fluids, followed by the administration of medical therapy (octreotide and prophylactic antibiotics), and finally performing definitive therapeutic endoscopy.
In any unstable patient with severe upper gastrointestinal bleeding, securing the ABCs (Airway, Breathing, Circulation) is paramount. Large-bore intravenous access and volume resuscitation must occur first. Following this, for suspected variceal bleeding, octreotide is given to decrease portal pressure, and prophylactic antibiotics (like ceftriaxone) are given to prevent infectious complications. Endoscopy is performed only after the patient is appropriately resuscitated to safely identify and treat the bleeding source.

Step-by-Step Solution

1
Prioritize Circulation (ABCs)
Placement of large-bore IVs and administration of fluids.
Prevention of cardiovascular collapse is the most urgent need in a hypotensive, bleeding patient.
2
Initiate directed medical therapy for suspected variceal hemorrhage
Administration of octreotide and antibiotics.
Octreotide causes splanchnic vasoconstriction to slow bleeding, while prophylactic antibiotics significantly reduce mortality and rebleeding rates in cirrhotic patients.
3
Proceed to definitive management
Perform esophagogastroduodenoscopy.
Once stabilized, endoscopy allows for visual identification of the bleeding source and therapeutic intervention such as variceal band ligation.

Key Concept

Sequential management of acute variceal hemorrhage focuses on initial hemodynamic resuscitation, followed by medical therapy (vasoactive agents and antibiotics), and lastly endoscopic intervention.
Question 829Question →

A 28-year-old man with a history of intravenous drug use presents to the emergency department with a 2-day history of high fever, chills, and severe fatigue. Temperature is 39.4°C (102.9°F), blood pressure is 105/65 mm Hg, and pulse is 118/min. Physical examination reveals a new holosystolic murmur at the left lower sternal border and pinpoint petechiae on the conjunctivae. Arrange the following management steps in the most appropriate sequential order for this patient.

Drag items to arrange them in the correct order

Show answer & explanation

Answer

The correct sequence of management for acute infective endocarditis is to first obtain multiple blood cultures, then initiate empiric broad-spectrum antibiotics, followed by an echocardiogram, and finally narrow the antibiotic therapy based on culture results.
The correct sequence prioritizes microbiologic diagnosis by drawing blood cultures first, followed immediately by empiric antibiotics to treat the severe infection. Echocardiography is then performed for definitive diagnosis, and finally, therapy is narrowed based on culture results to adhere to antimicrobial stewardship principles.

Step-by-Step Solution

1
Recognize the clinical presentation of acute infective endocarditis.
The patient has a high fever, new murmur, peripheral stigmata (petechiae), and a history of intravenous drug use, highly suggestive of acute right-sided infective endocarditis.
Establishing the presumptive diagnosis dictates the urgency and sequence of the subsequent interventions.
2
Determine the first priority in a potentially bacteremic patient.
Blood cultures must be drawn.
Drawing cultures before giving antibiotics is essential to prevent sterile cultures, which would severely complicate definitive, targeted therapy later.
3
Determine the next immediate step after drawing cultures.
Start empiric broad-spectrum antibiotics.
The patient is acutely ill; delaying antibiotics for imaging can lead to rapid clinical deterioration and increased mortality.
4
Select the appropriate diagnostic imaging modality.
Perform a transthoracic echocardiogram (TTE).
TTE is the initial imaging modality of choice to visualize vegetations and assess valvular function, completing the diagnostic workup.
5
Determine the final step in the therapeutic pathway.
Narrow the antibiotic therapy.
Once the organism is identified and susceptibilities are known, transitioning to narrow-spectrum therapy improves efficacy, reduces toxicity, and prevents antimicrobial resistance.

Key Concept

In patients with acute, severe suspected infective endocarditis, blood cultures must be drawn prior to the immediate initiation of empiric antibiotics, followed by echocardiography and subsequent tailoring of antibiotics once sensitivities are available.
Estimated Time:1m 0s
Question 830Question →

A pediatric clinic is establishing a new electronic medical record protocol that automatically prompts physicians to order specific universal screening tests during well-child visits. The clinic director wants to ensure the prompts appear at the correct milestone visits for healthy, asymptomatic children with no known risk factors. Arrange the following universal screening interventions in chronological order according to the earliest age at which the system should first prompt the physician to perform them.

Drag items to arrange them in the correct order

Show answer & explanation

Answer

The correct sequence is: Autism screening (18 months), Blood pressure measurement (3 years), Dyslipidemia screening (9 to 11 years), Depression screening (12 years), and HIV screening (15 to 18 years).
The American Academy of Pediatrics (AAP) Bright Futures guidelines establish a standardized timeline for universal screening in asymptomatic children to detect conditions early. The exact chronological onset for these universal screenings is: autism spectrum disorder (18 months), blood pressure (3 years), dyslipidemia (9 to 11 years), major depressive disorder (12 years), and human immunodeficiency virus (15 to 18 years).

Step-by-Step Solution

1
Determine the earliest recommended age for autism spectrum disorder screening.
18 months.
The American Academy of Pediatrics recommends universal screening for autism at the 18-month and 24-month well-child visits.
2
Identify the onset age for routine blood pressure measurement.
3 years.
Universal blood pressure screening begins at age 3 and continues annually.
3
Establish the timeframe for universal dyslipidemia screening.
9 to 11 years.
A universal lipid profile is drawn once between ages 9 and 11, prior to the physiological lipid changes associated with puberty.
4
Recall the starting age for universal depression screening.
12 years.
Annual screening for major depressive disorder begins universally at age 12.
5
Determine the age range for universal HIV screening.
15 to 18 years.
Routine HIV screening is recommended at least once between the ages of 15 and 18, reflecting the onset of sexual activity and other risks in adolescence.

Key Concept

Chronology of universal pediatric preventive care and screening guidelines.
Estimated Time:1m 30s
Question 831Question →

A 62-year-old woman with a body mass index of 34 kg/m² presents to the clinic with chronic, progressive bilateral knee pain. She notes the pain worsens with weight-bearing activities, such as walking up stairs, and is relieved by rest. She experiences morning stiffness in her knees lasting approximately 15 minutes. Physical examination reveals bony enlargement, crepitus, and a limited range of motion in both knees, without significant warmth or large effusions. Radiographs demonstrate asymmetric joint space narrowing, subchondral sclerosis, and prominent osteophyte formation. Arrange the following management steps for this patient's condition in the most appropriate sequential order, progressing from initial conservative measures to definitive advanced interventions.

Drag items to arrange them in the correct order

Show answer & explanation

Answer

The correct sequence of management is: 1) Weight loss, physical therapy, and topical NSAIDs; 2) Oral NSAIDs or duloxetine; 3) Intra-articular glucocorticoid injections; 4) Orthopedic surgery referral.
The management of knee osteoarthritis follows a stepwise escalation to balance efficacy and safety. Initial therapy involves nonpharmacologic measures (weight loss, exercise) and topical NSAIDs, which minimize systemic exposure. If inadequate, therapy is escalated to oral NSAIDs or duloxetine. For continued severe symptoms or acute flares, intra-articular glucocorticoid injections provide targeted relief. Finally, when all medical therapies have been exhausted and the patient's quality of life is severely impacted, referral for total knee arthroplasty is indicated.

Step-by-Step Solution

1
Identify the patient's diagnosis based on the clinical and radiographic presentation.
The patient has symptomatic knee osteoarthritis, supported by her age, obesity, mechanical joint pain, brief morning stiffness, and classic radiographic findings (joint space narrowing, osteophytes, subchondral sclerosis).
Establishing the correct diagnosis and baseline disease severity is the prerequisite for appropriate stepwise management.
2
Determine the first-line therapy for knee osteoarthritis according to current clinical guidelines.
Topical nonsteroidal anti-inflammatory drugs (NSAIDs), weight loss, and physical therapy are strongly recommended as the initial interventions.
These conservative measures provide localized and functional benefits while avoiding the gastrointestinal and cardiovascular risks associated with systemic oral medications.
3
Identify the appropriate sequence for escalating medical therapy if initial measures fail.
Oral NSAIDs (or duloxetine) should be trialed next, followed by intra-articular glucocorticoid injections for localized, refractory symptom flares.
Escalation to systemic oral agents and invasive intra-articular procedures should occur sequentially to balance symptom relief with the increasing risks of adverse side effects.
4
Determine the definitive treatment for end-stage, medically refractory disease.
Orthopedic referral for total knee arthroplasty is the final step in the sequence.
Joint replacement surgery is indicated when all non-surgical interventions have failed and the disease severely impairs the patient's quality of life and mobility.

Key Concept

Stepwise escalation of therapy in knee osteoarthritis prioritizes conservative lifestyle modifications and localized treatments before advancing to systemic medications, intra-articular injections, and ultimately definitive surgery.
Estimated Time:1m 0s
Question 832Question →

A 21-year-old woman with type 1 diabetes mellitus is brought to the emergency department due to lethargy, abdominal pain, and vomiting. She stopped taking her insulin two days ago because she was unable to eat. Her blood pressure is 88/55 mm Hg88/55 \text{ mm Hg}, heart rate is 132/min132\text{/min}, and respiratory rate is 26/min26\text{/min} with deep, sighing breaths. Mucous membranes are markedly dry. Laboratory studies reveal:

Laboratory StudyResult
Serum glucose520 mg/dL520 \text{ mg/dL}
Serum sodium132 mEq/L132 \text{ mEq/L}
Serum potassium2.9 mEq/L2.9 \text{ mEq/L}
Serum bicarbonate10 mEq/L10 \text{ mEq/L}
Arterial pH7.157.15

Arrange the following targeted management steps in the most appropriate chronological sequence according to standard diabetic ketoacidosis (DKA) protocols.

Drag items to arrange them in the correct order

Show answer & explanation

Answer

The correct chronological sequence for this patient's management is: 1) Administer a rapid intravenous bolus of 0.9% sodium chloride, 2) Initiate intravenous potassium chloride supplementation, 3) Start a continuous intravenous infusion of regular insulin, and 4) Add 5% dextrose to the maintenance intravenous fluids.
The initial priority in diabetic ketoacidosis (DKA) is restoring intravascular volume with 0.9%0.9\% normal saline to reverse hypovolemic shock and improve renal perfusion. Next, serum potassium must be evaluated. Although patients with DKA have total body potassium depletion, serum levels are often falsely normal or elevated due to extracellular shifts from acidosis and insulin deficiency. In this patient, the serum potassium is already severely low (2.9 mEq/L2.9 \text{ mEq/L}). Because insulin drives potassium into cells, insulin therapy MUST be delayed until serum potassium is restored to at least 3.3 mEq/L3.3 \text{ mEq/L} to avoid fatal arrhythmias. Once potassium is appropriately replaced, an intravenous regular insulin infusion is started to halt ketogenesis. Finally, when blood glucose levels fall to approximately 200 mg/dL200 \text{ mg/dL}, 5%5\% dextrose is added to the intravenous fluids. This prevents hypoglycemia while allowing the continuous insulin infusion to remain active until the anion gap successfully closes.

Step-by-Step Solution

1
Assess hemodynamic status and establish immediate priorities.
Patient is in hypovolemic shock (BP 88/55 mm Hg88/55 \text{ mm Hg}). The first step must be fluid resuscitation with 0.9%0.9\% normal saline.
Restoring intravascular volume improves renal perfusion and begins the process of lowering serum osmolality.
2
Evaluate the initial serum potassium level before giving insulin.
Potassium is 2.9 mEq/L2.9 \text{ mEq/L}, which is below the critical threshold of 3.3 mEq/L3.3 \text{ mEq/L}.
Insulin drives potassium intracellularly. Giving insulin now would cause life-threatening hypokalemia. Potassium repletion is the immediate next step.
3
Determine the timing for insulin administration.
Intravenous regular insulin can only be started after serum potassium is confirmed to be >3.3 mEq/L> 3.3 \text{ mEq/L}.
Insulin is required to halt ketogenesis and close the anion gap, but must be timed safely relative to potassium correction.
4
Plan for the transition phase of DKA management.
Dextrose (5%5\%) must be added to the intravenous fluids once serum glucose falls below 200 mg/dL200 \text{ mg/dL}.
To prevent hypoglycemia while continuing the insulin drip required to resolve the underlying ketoacidosis.

Key Concept

The acute management sequence of Diabetic Ketoacidosis (DKA) strictly prioritizes fluid resuscitation, followed by assessment and correction of severe hypokalemia prior to the initiation of insulin therapy.
Question 833Question →

A 5-year-old boy is brought to the clinic by his parents for a routine health maintenance visit prior to starting kindergarten. He was born at 39 weeks gestation via uncomplicated spontaneous vaginal delivery. Vital signs include temperature 37.1°C (98.8°F), heart rate 95/min, and blood pressure 92/58 mm Hg. Physical examination reveals a cooperative, healthy-appearing child. His parents report that they recently immigrated, and his last well-child visit was at age 4 months. He is significantly behind on his immunizations, and a catch-up schedule is initiated today. The physician also reviews the boy's developmental history, and the parents recall his past progress clearly. Arrange the following developmental milestones in the expected chronological order of their acquisition in a normally developing child, from earliest to latest.

Drag items to arrange them in the correct order

Show answer & explanation

Answer

The milestones emerge chronologically as follows: Sitting without support (6 months), Utilizing a two-finger pincer grasp (12 months), Kicking a ball forward (2 years), Copying a circle (3 years), and Skipping on alternating feet (5 years).
Developmental milestones are evaluated during pediatric preventive care visits to ensure normal progression. The sequence begins in infancy with sitting without support (6 months), progresses to fine motor dexterity with a neat two-finger pincer grasp (12 months), advances to early toddler gross motor skills like kicking a ball (2 years), continues with fine motor coordination such as copying a circle (3 years), and culminates in advanced gross motor coordination like skipping (5 years).

Step-by-Step Solution

1
Determine the age of expected acquisition for sitting without support.
6 months
Infants typically develop the core strength to sit up without propping by 6 months of age.
2
Determine the age of expected acquisition for utilizing a two-finger pincer grasp.
12 months
Fine motor skills progress from a raking grasp at 6 months to a neat, two-finger pincer grasp by 12 months.
3
Determine the age of expected acquisition for kicking a ball forward.
24 months (2 years)
Toddlers refine their balance and coordination to kick a ball and walk up stairs one step at a time by 2 years of age.
4
Determine the age of expected acquisition for copying a circle.
36 months (3 years)
Fine motor skills advance to drawing simple shapes, with a circle typically mastered at 3 years of age.
5
Determine the age of expected acquisition for skipping on alternating feet.
60 months (5 years)
Complex gross motor coordination, such as skipping and catching a bounced ball, is typically achieved by 5 years of age.

Key Concept

Normal pediatric developmental milestones follow a predictable chronological sequence and are evaluated alongside immunizations during well-child visits to identify any neurological or physical delays.
Question 834Question →

A 45-year-old man presents to the clinic with complaints of progressive enlargement of his hands and feet over the past two years, requiring him to buy larger shoes and a new wedding ring. He also reports excessive sweating and recently began snoring loudly at night. On physical examination, he has a prominent jaw, an enlarged nose, and macroglossia. You suspect a growth hormone-secreting pituitary adenoma. Arrange the following steps in the most appropriate chronological sequence for the diagnosis and initial management of this patient's condition.

Drag items to arrange them in the correct order

Show answer & explanation

Answer

The correct sequence is: 1) Measurement of IGF-1, 2) Oral glucose suppression test with GH measurement, 3) MRI of the pituitary gland, and 4) Evaluation for transsphenoidal surgery.
The standard diagnostic and management algorithm for suspected acromegaly proceeds in a stepwise fashion from screening to confirmation to localization to treatment. Initial screening is performed with an IGF-1 level, which integrates pulsatile growth hormone secretion over time. If elevated, the diagnosis must be biochemically confirmed using an oral glucose suppression test. Once biochemical excess is definitively proven, a pituitary MRI is obtained to localize the source (typically a somatotroph adenoma). Finally, transsphenoidal surgical resection is the first-line treatment for the vast majority of cases.

Step-by-Step Solution

1
Identify the suspected diagnosis based on the clinical presentation.
The patient's enlarging hands and feet, coarse facial features, and macroglossia strongly suggest acromegaly.
Recognizing the clinical syndrome determines the correct diagnostic pathway.
2
Determine the best initial screening test.
Serum IGF-1 level is selected as the first step.
Growth hormone is secreted in a pulsatile manner, making random measurements unreliable. IGF-1 provides a stable indicator of overall growth hormone excess.
3
Determine the confirmatory diagnostic test.
An oral glucose suppression test is placed second.
Biochemical confirmation of autonomous growth hormone secretion is required before imaging. Normal physiology involves suppression of growth hormone by a glucose load.
4
Select the appropriate imaging modality.
Pituitary MRI is placed third.
Imaging must only follow biochemical confirmation to avoid the misattribution of symptoms to incidental, nonfunctioning pituitary microadenomas.
5
Determine the definitive initial management.
Surgical evaluation is placed last.
Once the adenoma is functionally and anatomically characterized, transsphenoidal surgery is the definitive primary therapy.

Key Concept

The diagnostic workup for acromegaly requires sequential biochemical testing (screening with IGF-1, followed by confirmatory oral glucose suppression testing) prior to anatomical localization with a pituitary MRI.
Question 835Question →

A 3535-year-old man who recently emigrated from a country with high tuberculosis endemicity presents to the emergency department. He reports a 66-week history of a persistent, blood-tinged cough, subjective fevers, drenching night sweats, and a 66-kg (1313-lb) weight loss. While in the crowded triage area, he is actively coughing. His vital signs show a temperature of 38.2∘C38.2^\circ\text{C} (100.8∘F100.8^\circ\text{F}). Arrange the following steps in the most appropriate chronological order for the optimal management of this patient.

Drag items to arrange them in the correct order

Show answer & explanation

Answer

The correct sequence of actions is to first establish airborne infection isolation, followed by initial diagnostic imaging with a chest radiograph, then obtaining definitive microbiological sputum samples, and finally initiating multidrug antituberculous therapy.
The management of suspected active pulmonary tuberculosis follows a strict chronological progression prioritizing public health, then diagnosis, then treatment. The immediate placement of a surgical mask and transfer to an airborne infection isolation room prevents nosocomial transmission. Once isolated, a chest radiograph serves as the initial diagnostic step to quickly evaluate for typical cavitary or infiltrative disease. Following this, consecutive sputum samples for AFB smear and culture must be obtained to confirm the diagnosis and secure isolates for susceptibility testing. Finally, a four-drug treatment regimen is initiated only after all diagnostic samples are successfully collected.

Step-by-Step Solution

1
Prioritize infection control by placing a mask on the patient and moving them to a negative-pressure isolation room.
Prevents the aerosolized spread of Mycobacterium tuberculosis to other patients and healthcare staff.
Airborne transmission risk is highest when an untreated patient is actively coughing in a shared space.
2
Perform initial diagnostic imaging with a chest radiograph.
Evaluates for classic signs of primary or reactivation tuberculosis, such as upper lobe infiltrates or cavitary lesions.
Provides rapid supportive evidence for the clinical suspicion before waiting for lengthy laboratory tests.
3
Collect 33 consecutive sputum samples for AFB smear and culture.
Secures the biological samples needed for definitive microbiological diagnosis and eventual drug susceptibility testing.
Samples must be collected prior to initiating antibiotics to ensure the highest diagnostic yield.
4
Initiate a four-drug empiric therapy regimen.
Begins the lengthy process of eradicating the mycobacterial infection.
Pharmacotherapy is the definitive treatment but should only be started after isolation and appropriate diagnostic sampling.

Key Concept

In patients with suspected active pulmonary tuberculosis, strict airborne infection control (masking and negative-pressure isolation) is the absolute first step in management, preceding all diagnostic testing and therapeutic interventions.
Estimated Time:45s
Question 836Question →

A 45-year-old man with a history of intravenous drug use presents to the emergency department with a 1-week history of high fevers, chills, and profound fatigue. His temperature is 39.2°C (102.6°F), blood pressure is 110/70 mm Hg, and heart rate is 115/min. Physical examination is notable for a new early diastolic murmur heard best at the left lower sternal border, and painless erythematous macules on the palms of his hands. Laboratory results show a leukocyte count of 18,000/mm³ with a left shift. Arrange the following diagnostic and therapeutic steps in the most appropriate chronological order for managing this patient's acute presentation.

Drag items to arrange them in the correct order

Show answer & explanation

Answer

The correct sequence is to first obtain blood cultures, then initiate empiric antibiotics, followed by a transthoracic echocardiogram, and finally a transesophageal echocardiogram if needed.
The management of acute infective endocarditis requires rapid and sequential action. Blood cultures are the most critical diagnostic step and must be drawn first to ensure pathogen identification. Because acute endocarditis can be rapidly fatal, empiric broad-spectrum antibiotics must be started immediately following the blood draw, before imaging confirms the diagnosis. Once therapy is initiated, a transthoracic echocardiogram (TTE) is performed as the initial imaging modality due to its non-invasive nature and wide availability. If the TTE is negative or technically limited (which is common for small vegetations), a transesophageal echocardiogram (TEE) is the definitive next step due to its superior sensitivity.

Step-by-Step Solution

1
Identify the primary clinical syndrome.
The patient presents with fever, a new murmur (suggestive of aortic regurgitation), and Janeway lesions, which is highly suspicious for acute infective endocarditis.
Recognizing the acute, potentially life-threatening nature of the infection dictates the urgency of the management sequence.
2
Determine the first critical diagnostic intervention.
Multiple sets of blood cultures must be obtained before any other action.
Administering antibiotics prior to drawing cultures drastically reduces the chance of isolating the pathogen, which is required for tailoring targeted antimicrobial therapy.
3
Determine the timing of pharmacologic therapy.
Empiric antibiotics (e.g., vancomycin to cover MRSA) are administered immediately after cultures are drawn.
Delaying antimicrobial therapy in acute endocarditis can lead to rapid valvular destruction, heart failure, or severe septic embolization.
4
Sequence the imaging modalities.
TTE is ordered first, followed by TEE if the TTE is negative.
TTE is non-invasive and highly specific, making it the appropriate initial test. TEE is more invasive but more sensitive, used as a step-up diagnostic tool when initial imaging is indeterminate.

Key Concept

In patients with suspected acute infective endocarditis, the critical management sequence is to draw multiple blood cultures first, immediately start broad-spectrum empiric antibiotics, and then proceed with echocardiographic imaging (TTE followed by TEE if necessary).
Estimated Time:1m 30s
Question 837Question →

A 42-year-old woman is diagnosed with severe, seropositive rheumatoid arthritis characterized by symmetric polyarthritis involving the metacarpophalangeal joints, morning stiffness lasting 2 hours, and bone erosions on radiography. She is preparing to begin long-term pharmacotherapy. Arrange the following clinical steps in the correct chronological sequence according to current consensus guidelines for the escalating management of rheumatoid arthritis.

Drag items to arrange them in the correct order

Show answer & explanation

Answer

The correct chronological sequence is: initiate methotrexate, evaluate the clinical response at 3 months, perform an interferon-gamma release assay, prescribe a TNF inhibitor, and finally switch to an alternative mechanism biologic if the TNF inhibitor fails.
Rheumatoid arthritis management follows a strict algorithmic escalation. Methotrexate is the universal first step. Because csDMARDs require time to work, a 3-month evaluation is necessary before deciding on failure. If the disease remains active, biologic escalation is warranted. However, the initiation of any biologic (especially TNF inhibitors) requires immediate prior screening for latent tuberculosis and hepatitis B/C to prevent fatal reactivation. Once cleared, the TNF inhibitor is added. Finally, if the patient fails the TNF inhibitor trial, standard practice is to switch to a biologic with a different mechanism of action rather than cycling through another TNF inhibitor.

Step-by-Step Solution

1
Identify the standard first-line pharmacotherapy for a new diagnosis of severe rheumatoid arthritis.
The first step is initiating methotrexate alongside folic acid supplementation.
Methotrexate is the most effective initial csDMARD, serves as the anchor drug for rheumatoid arthritis, and reduces the risk of anti-drug antibodies if biologics are used later.
2
Determine the appropriate timeframe for evaluating the initial therapy.
The second step is evaluating the patient at a 3-month follow-up.
Conventional DMARDs take several months to reach full efficacy; premature escalation before an adequate trial should be avoided.
3
Recognize the required safety prerequisites before escalating to biologic therapy.
The third step is performing an interferon-gamma release assay (IGRA).
Biologics strongly increase the risk of tuberculosis reactivation, making infectious screening a mandatory chronological gatekeeper before their initiation.
4
Select the appropriate next line of therapy following csDMARD failure.
The fourth step is prescribing a TNF inhibitor as an add-on therapy.
Adding a biologic DMARD to background methotrexate is the standard of care for methotrexate non-responders.
5
Determine the management strategy if the initial biologic fails.
The final step is switching to an alternative mechanism biologic.
Patients who do not respond to a TNF inhibitor are typically transitioned to a biologic with a different mechanism of action, such as an IL-6 inhibitor or CD20 monoclonal antibody.

Key Concept

The stepwise escalation of pharmacotherapy in rheumatoid arthritis emphasizes initial csDMARD use, mandatory infectious screening immediately prior to biologic therapy, and class-switching upon primary biologic failure.
Estimated Time:1m 30s
Question 838Question →

A 3434-year-old woman is evaluated in the emergency department for a 22-day history of heavy gingival bleeding, recurrent epistaxis, and a large bruise on her thigh after minor trauma. Her temperature is 37.9∘C37.9^\circ\text{C} (100.2∘F100.2^\circ\text{F}), pulse is 112/min112/\text{min}, and blood pressure is 105/65 mm Hg105/65 \text{ mm Hg}. Physical examination reveals pallor, diffuse petechiae over the chest and extremities, and continuous oozing of blood from the intravenous line insertion site. Laboratory studies show:

TestValueNormal Range
Hemoglobin7.8 g/dL7.8 \text{ g/dL}12.0−15.5 g/dL12.0-15.5 \text{ g/dL}
Platelet count18,000/mm318,000/\text{mm}^3150,000−400,000/mm3150,000-400,000/\text{mm}^3
Leukocyte count32,000/mm332,000/\text{mm}^34,500−11,000/mm34,500-11,000/\text{mm}^3
Prothrombin time21 sec21 \text{ sec}11−15 sec11-15 \text{ sec}
aPTT45 sec45 \text{ sec}25−40 sec25-40 \text{ sec}
Fibrinogen80 mg/dL80 \text{ mg/dL}200−400 mg/dL200-400 \text{ mg/dL}

A peripheral blood smear demonstrates numerous atypical mononuclear cells with folded nuclei, heavily granulated cytoplasm, and bundles of rod-shaped cytoplasmic inclusions.

Arrange the following management steps in the most appropriate chronological sequence for this patient.

Drag items to arrange them in the correct order

Show answer & explanation

Answer

The correct sequence is: Administer all-trans retinoic acid (ATRA) -> Perform bone marrow aspiration and biopsy -> Obtain molecular confirmation of the PML-RARA fusion -> Initiate definitive induction therapy with arsenic trioxide.
The presentation of pancytopenia, severe coagulopathy (prolonged PT/aPTT, low fibrinogen), and a peripheral smear showing atypical cells with prominent bundles of Auer rods (faggot cells) is the classic manifestation of Acute Promyelocytic Leukemia (APL) complicated by disseminated intravascular coagulation (DIC). Because this coagulopathy can rapidly lead to fatal hemorrhage, the absolute first step in management is the immediate administration of all-trans retinoic acid (ATRA). This decision must be based purely on clinical and morphologic suspicion. ATRA forces the differentiation of leukemic promyelocytes into mature neutrophils, rapidly improving the coagulopathy. Once ATRA is administered and the patient's bleeding diathesis is acutely managed (often with cryoprecipitate, fresh frozen plasma, and platelets), a bone marrow aspiration and biopsy should be performed to secure the diagnostic material. The samples obtained are then sent for cytogenetic or molecular testing to confirm the presence of the t(15;17)\text{t}(15;17) translocation, which creates the PML-RARA fusion protein. Finally, once the diagnosis is definitively confirmed, combination induction therapy (often incorporating arsenic trioxide and/or an anthracycline alongside ATRA) is initiated to achieve complete remission.

Step-by-Step Solution

1
Analyze the clinical presentation and laboratory findings.
The patient has pancytopenia, clinical signs of disseminated intravascular coagulation (DIC), and atypical cells with bundles of Auer rods (faggot cells).
These findings are highly specific for Acute Promyelocytic Leukemia (APL), a medical emergency driven by the PML-RARA fusion protein.
2
Determine the most urgent, life-saving intervention.
Administration of all-trans retinoic acid (ATRA) is the immediate priority.
APL causes severe DIC leading to a high rate of early hemorrhagic death. ATRA induces differentiation of leukemic promyelocytes, rapidly resolving the coagulopathy, and must not be delayed.
3
Sequence the diagnostic and definitive treatment steps following initial stabilization.
Bone marrow biopsy is followed by molecular testing, which is then followed by targeted combination therapy.
Tissue acquisition must precede molecular confirmation. Once the specific genetic lesion is confirmed, final chemotherapeutic adjustments (such as adding arsenic trioxide) are made.

Key Concept

In patients with suspected Acute Promyelocytic Leukemia (APL) presenting with severe coagulopathy, all-trans retinoic acid (ATRA) must be administered immediately based on clinical suspicion, prior to bone marrow biopsy and molecular confirmation, to prevent fatal hemorrhage.
Estimated Time:1m 30s
Question 839Question →

An 18-year-old male with homozygous sickle cell disease is brought to the emergency department due to a two-day history of progressively worsening chest pain, productive cough, and subjective fevers. Initial vital signs show a temperature of 38.8°C (101.8°F), blood pressure of 118/76 mm Hg, heart rate of 112/min, and respiratory rate of 26/min. Pulse oximetry reveals an oxygen saturation of 87% on room air. Physical examination is notable for scleral icterus and decreased breath sounds with crackles over the right lower lung fields. Laboratory evaluation demonstrates a hemoglobin of 7.2 g/dL, leukocyte count of 16,500/mm³, and reticulocyte count of 12%. A chest radiograph reveals a new consolidation in the right lower lobe.

What is the most appropriate chronological sequence for the management of this patient's condition?

Drag items to arrange them in the correct order

Show answer & explanation

Answer

The correct chronological sequence is to first administer supplemental oxygen and analgesia, followed by empiric intravenous antibiotics, then perform an exchange red blood cell transfusion if clinical deterioration occurs, and finally prescribe daily oral hydroxyurea for long-term prevention after recovery.
The management of acute chest syndrome (ACS) follows a stepwise approach based on acuity. The absolute first priority is stabilization with supplemental oxygen to reverse hypoxia-induced sickling, accompanied by rapid pain control. Once the patient is stabilized, empiric antibiotics (e.g., ceftriaxone and azithromycin) are given because underlying pulmonary infections are the most common trigger for ACS and cannot be reliably distinguished from infarction. If the patient's respiratory status continues to decline or if they present with severe disease (e.g., needing mechanical ventilation), red blood cell exchange transfusion is indicated to rapidly replace HbS with normal hemoglobin. Finally, after the patient has recovered from the acute episode, long-term preventive therapy with hydroxyurea is initiated in the outpatient setting to increase fetal hemoglobin and reduce the frequency of future crises.

Step-by-Step Solution

1
Analyze the clinical presentation.
The patient has sickle cell disease and presents with fever, chest pain, hypoxia, and a new pulmonary infiltrate, which is diagnostic for acute chest syndrome (ACS).
Establishing the diagnosis of ACS determines the specific treatment pathway.
2
Determine the immediate resuscitative priorities.
Hypoxia and pain promote further red blood cell sickling. Providing supplemental oxygen and parenteral analgesics is the first necessary intervention.
Reversing the acute triggers of sickling prevents the microvascular occlusion from worsening.
3
Identify the underlying trigger and initial medical therapy.
Infection is a leading cause of ACS. Empiric antibiotics covering typical and atypical organisms must be started promptly after initial stabilization.
Pneumonia often triggers or is indistinguishable from ACS, making early antimicrobial therapy the standard of care.
4
Determine the intervention for potential clinical deterioration.
If respiratory status worsens despite initial measures, an exchange transfusion is necessary to acutely lower the hemoglobin S concentration.
Rapid removal of sickled cells restores adequate microvascular perfusion and oxygenation in refractory or severe cases.
5
Establish a long-term preventive plan.
Hydroxyurea therapy is planned for the outpatient setting once the patient recovers from the acute crisis.
Hydroxyurea increases fetal hemoglobin (HbF) and is indicated to prevent future episodes, but it has no role in acute management.

Key Concept

The management of acute chest syndrome in sickle cell disease begins with immediate supportive care (oxygen, pain control, fluids), followed by empiric antibiotics for potential infectious triggers, exchange transfusion for severe or refractory cases, and finally, long-term prevention with hydroxyurea.
Estimated Time:1m 30s
Question 840Question →

A 19-year-old man with type 1 diabetes mellitus is brought to the emergency department due to lethargy, deep and rapid breathing, and a fruity breath odor. Laboratory results show a blood glucose of 580 mg/dL580 \text{ mg/dL}, arterial pH of 7.127.12, serum bicarbonate of 10 mEq/L10 \text{ mEq/L}, and a serum potassium of 5.6 mEq/L5.6 \text{ mEq/L}. He is diagnosed with severe diabetic ketoacidosis (DKA).

Arrange the following management steps in the optimal chronological sequence for this patient.

Drag items to arrange them in the correct order

Show answer & explanation

Answer

The optimal sequence for managing diabetic ketoacidosis is: initial fluid resuscitation with 0.9%0.9\% normal saline, followed by an intravenous insulin infusion, addition of potassium when levels drop into the normal range, addition of dextrose when glucose reaches 200 mg/dL200 \text{ mg/dL}, and finally transitioning to subcutaneous insulin when the anion gap closes.
Management of DKA requires a strict protocol to safely resolve the metabolic derangements. Initial fluid resuscitation with 0.9%0.9\% normal saline restores intravascular volume. Once potassium is confirmed >3.3 mEq/L>3.3 \text{ mEq/L}, an intravenous regular insulin infusion is started to halt ketogenesis. As insulin therapy shifts potassium intracellularly, potassium must be added to maintenance fluids when serum levels drop <5.2 mEq/L<5.2 \text{ mEq/L}. Because blood glucose drops faster than ketones are cleared, 5%5\% dextrose is added when glucose reaches 200 mg/dL200 \text{ mg/dL} to prevent hypoglycemia while maintaining the insulin drip. Finally, transition to subcutaneous insulin occurs once the anion gap closes and the patient can tolerate oral intake.

Step-by-Step Solution

1
Administer a rapid intravenous bolus of 0.9%0.9\% normal saline
Restores intravascular volume and tissue perfusion
Severe osmotic diuresis leads to profound volume depletion. Reversing this shock state is the absolute top priority.
2
Initiate a continuous intravenous regular insulin infusion
Halts lipolysis and ketogenesis
Insulin drives glucose into cells and stops ketone production. It can be safely started because the initial potassium is well above the 3.3 mEq/L3.3 \text{ mEq/L} threshold.
3
Add potassium chloride to the intravenous fluids once serum potassium falls below 5.2 mEq/L5.2 \text{ mEq/L}
Prevents severe hypokalemia
Despite total body potassium depletion, initial serum potassium is often high or normal due to acidemia. As insulin therapy drives potassium into cells, levels drop rapidly, requiring proactive supplementation.
4
Add 5%5\% dextrose to the intravenous fluids once serum glucose reaches 200 mg/dL200 \text{ mg/dL}
Prevents hypoglycemia while allowing insulin to continue
Blood glucose levels typically normalize faster than the ketoacidosis resolves. Dextrose must be given so the insulin drip can safely continue to close the anion gap.
5
Transition to a subcutaneous basal-bolus insulin regimen
Establishes long-term glycemic control
This transition is safe only when the acute crisis has resolved (evidenced by a closed anion gap) and the patient is able to eat.

Key Concept

Diabetic Ketoacidosis (DKA) Stepwise Management
Estimated Time:2m 0s
PreviousPage 42 / 85Next
All practice questions — USMLE Step 2 CK | Examkin